Medication info

Neuropehnem 500 mg (Meropenem Hydrate)

Prescription medicationInjections정맥
Ingredient · strength
Meropenem Hydrate›500mg / 1 vial
Manufacturer / importer
제일약품(주)
Appearance
A colorless, transparent vial filled with a crystalline powder that is white to light yellow.
Packaging
10 vials
Approval status
Active

MFDS item code 200909379 · Notified 2009.12.30 · Insurance code 645403371

Summary

Main use
Treatment of various bacterial infections (sepsis, respiratory infections, etc.)
Who receives it
Adults · Children
Adult administration
As Meropenem Hydrate, administer 0.5 to 1 g (activity) daily divided into 2 to 3 doses by slow intravenous infusion over more than 30 minutes. For suspected infections in patients with pathogenic pneumonia, peritonitis, and neutropenia, administer 1 g (activity) by slow intravenous infusion every 8 hours. For cystic fibrosis and meningitis, administer 2 g (activity) by slow intravenous infusion every 8 hours.
Child administration
For bacterial meningitis in children over 3 months of age, administer 40 mg per kg of body weight every 8 hours by slow intravenous infusion over more than 30 minutes, depending on the pathogen's susceptibility and the patient's condition, and type of infection. Severe

Ingredients

Manufacturer
제일약품(주)

Efficacy & effects

Treatment of various bacterial infections (sepsis, respiratory infections, etc.)

  • Sepsis
  • superficial purulent diseases
  • lymphadenitis
  • perianal abscess
  • osteomyelitis
  • arthritis
  • wound infections
  • pneumonia
  • peritonsillar abscess
  • secondary infections of chronic respiratory diseases
  • lung abscess
  • empyema
View approved original text

This medication is effective against a variety of bacteria such as staphylococci, streptococci, enterococci, and Escherichia coli, and is used to treat various types of infections. Specifically, it is effective in treating sepsis and superficial purulent diseases, lymphadenitis, perianal abscess, and skin and soft tissue infections. It is also used in the treatment of infections in the surgical and orthopedic fields, including osteomyelitis, arthritis, and wound infections. It is effective for respiratory infections (pneumonia, peritonsillar abscess, etc.) and urinary tract infections (pyelonephritis, complicated cystitis, etc.), as well as biliary tract infections (cholecystitis, cholangitis, etc.). Additionally, it is used for the treatment of peritonitis, gynecological infections, otolaryngological infections, bacterial meningitis, suspected infections due to neutropenia, and the prevention of infections in cystic fibrosis patients. In other words, this medication helps improve patients' symptoms by treating various bacterial infections.

How it is given

Adult administration

As Meropenem Hydrate, administer 0.5 to 1 g (activity) daily divided into 2 to 3 doses by slow intravenous infusion over more than 30 minutes. For suspected infections in patients with pathogenic pneumonia, peritonitis, and neutropenia, administer 1 g (activity) by slow intravenous infusion every 8 hours. For cystic fibrosis and meningitis, administer 2 g (activity) by slow intravenous infusion every 8 hours.

Child administration

For bacterial meningitis in children over 3 months of age, administer 40 mg per kg of body weight every 8 hours by slow intravenous infusion over more than 30 minutes, depending on the pathogen's susceptibility and the patient's condition, and type of infection. Severe

Precautions

This medication should not be used in certain patients. For example, it should not be administered to patients who have experienced severe allergic reactions or shock to this drug, patients taking valproate sodium, and patients with hypersensitivity to this medication or similar antibiotics. Additionally, it should be used with caution in individuals with asthma or allergies, patients with kidney or liver issues, those with central nervous system diseases, the elderly, and infants, as they may experience more severe side effects. When using this medication, various side effects may occur, including shock, allergic reactions, blood abnormalities, liver function decline, kidney problems, gastrointestinal disturbances, central nervous system abnormalities, respiratory issues, and severe skin reactions. Symptoms should be reported to medical personnel immediately. This medication should be used only for the minimum period required to prevent resistant bacteria, and it is important to check its effectiveness through sensitivity testing before and during administration. Regular checks for liver function, kidney function, and blood tests should be conducted to detect any signs early and take appropriate action. This medication may interact with certain drugs, so it is essential to inform medical personnel of any other medications being taken, especially with valproate, antiepileptics, hormonal drugs, and anticoagulants. Women who are pregnant or may become pregnant should consider the risks and benefits cautiously before administration as it may pose a risk. If breastfeeding, it is advisable to avoid this medication as it may be excreted in breast milk. It is preferable not to use this medication in infants under 3 months old as safety and efficacy have not been established. The elderly may experience easier occurrence of side effects due to decreased bodily functions; hence, careful observation and dosage adjustments are recommended. This medication is for intravenous use only, should be used as soon as possible after reconstitution, and must be stored according to specified times and temperatures. Lastly, this medication may cause cross-reactivity with other beta-lactam antibiotics; therefore, patients with a history of allergic reactions to such drugs should consult medical personnel.

Side effects and when to seek care immediately

Serious side effects

Shock, anaphylaxis, urticaria, angioedema, rash, severe skin reactions (toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, erythema multiforme, acute generalized exanthematous pustulosis), liver failure, jaundice, fulminant hepatitis, acute renal failure, pseudomembranous colitis, asthma, respiratory distress, pulmonary edema, rhabdomyolysis, headache (severe headache and thunderclap headache), seizures, altered consciousness, central nervous system symptoms, thrombophlebitis, heart failure,

Mild side effects

  • Dizziness
  • diarrhea
  • tinnitus
  • sweating
  • warmth
  • erythema
  • itching
  • fever
  • redness
  • general flushing
Show 19 more
  • angioedema
  • pancytopenia
  • agranulocytosis
  • hemolytic anemia
  • hypochromic anemia
  • leukopenia
  • granulocytopenia
  • eosinophilia
  • thrombocytopenia
  • thrombocytosis
  • lymphocytosis
  • hemoglobin reduction
  • basophilia
  • atypical lymphocyte increase
  • erythrocytopenia
  • hematocrit decrease
  • hypokalemia
  • AST elevation
  • ALT elevation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air, preferably at room temperature between 1 degree and 30 degrees. This storage method helps maintain the drug's efficacy and prevents degradation.

Appearance and packaging

Appearance

A colorless, transparent vial filled with a crystalline powder that is white to light yellow.

Package unit

10 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.